(Q37794052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Celine Lewis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ray Jones

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

29 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

Journal of Genetic Counseling

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

80-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20878544%20AND%20SRC:MED&resulttype=core&format=json

Psychological well-being and coping in mothers of youths with autism, Down syndrome, or fragile X syndrome.

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Attitudes toward fragile X mutation carrier testing from women identified in a general population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

The impact of population based screening for carriers of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Primary care patients' personal illness models for depression: relationship to coping behavior and functional disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Carrier testing in haemophilia A and B: adult carriers' and their partners' experiences and their views on the testing of young females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Never again joy without sorrow: the effect on parents of a child with ataxia-telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Psychological well-being of mothers of youth with fragile X syndrome: syndrome specificity and within-syndrome variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Effects of genetic screening on perceptions of health: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Carrier testing in the fragile X syndrome: attitudes and opinions of obligate carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Carrier testing in fragile X syndrome: effect on self-concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Chromosomal abnormalities in couples with reproductive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Gender differences in psychosocial reactions to cystic fibrosis carrier testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Emotional reaction to fragile X premutation carrier tests among infertile women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Mothers' experiences of parenting a child with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Self-Concept: Validation of Construct Interpretations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Psychosocial adaptation in female partners of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

The relationship between anxiety, coping strategies and characteristics of patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Psychological and social consequences of community carrier screening programme for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

A targeted population carrier screening program for severe and frequent genetic diseases in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Benefits and burdens of genetic carrier identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10897-010-9327-8

21 January 2018

12 December 2020

Tay-Sachs screening: social and psychological impact

1 reference

12 December 2020

Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network

1 reference

12 December 2020

A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study

1 reference

12 December 2020

Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives.

1 reference

12 December 2020

Stigmatization of carrier status: social implications of heterozygote genetic screening programs

1 reference

12 December 2020

Perception of carrier status by cystic fibrosis siblings

1 reference

12 December 2020

Using mind mapping techniques for rapid qualitative data analysis in public participation processes

1 reference

12 December 2020

Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction

1 reference

12 December 2020

Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later

1 reference

12 December 2020

CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by "non-carrier" couples

1 reference

12 December 2020

Frequency of FMR1 premutation in individuals with ataxia and/or tremor and/or parkinsonism.

1 reference

12 December 2020

Prevention of thalassemia: experiences from Samui Island.

1 reference

12 December 2020

The Health Orientation Scale: a measure of feelings about sickle cell trait

1 reference

12 December 2020

Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice

1 reference

12 December 2020

Population screening for cystic fibrosis in Western Australia: community response

1 reference

12 December 2020

Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors

1 reference

12 December 2020